Fernandez, Baby Girl .
HRN: 23-83-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2023
CEFTAZIDIME 1GM (VIAL)
10/19/2023
10/25/2023
IV
100mg
Q8
Omphalitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes